Page 169 - Orange Book Cumulative Supplement 10 October 2012
P. 169
A - 32
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content
PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
MONTELUKAST SODIUM - SINGULAIR
N020830 002 NPP Mar 26, 2015
MONTELUKAST SODIUM - SINGULAIR
N021409 001 NPP Mar 26, 2015
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
N022321 001 7682633 Jun 19, 2027 U-1241
8158156 Jun 19, 2027 U-1241
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
N022321 002 7682633 Jun 19, 2027 U-1241
8158156 Jun 19, 2027 U-1241
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
N022321 003 7682633 Jun 19, 2027 U-1241
8158156 Jun 19, 2027 U-1241
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
N022321 004 7682633 Jun 19, 2027 U-1241
8158156 Jun 19, 2027 U-1241
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
N022321 005 7682633 Jun 19, 2027 U-1241
8158156 Jun 19, 2027 U-1241
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
N022321 006 7682633 Jun 19, 2027 U-1241
8158156 Jun 19, 2027 U-1241
NAFTIFINE HYDROCHLORIDE - NAFTIN
N019599 002 NS Jan 13, 2015
NEPAFENAC - NEPAFENAC
N203491 001 >A> NP Oct 16, 2015
NICOTINE - NICODERM CQ
N020165 004 8075911 May 22, 2021 DP
NICOTINE - NICODERM CQ
N020165 005 8075911 May 22, 2021 DP
NICOTINE - NICODERM CQ
N020165 006 8075911 May 22, 2021 DP
NILOTINIB HYDROCHLORIDE MONOHYDRATE - TASIGNA
N022068 001 8163904 Aug 23, 2028 DS DP
NILOTINIB HYDROCHLORIDE MONOHYDRATE - TASIGNA
N022068 002 8163904 Aug 23, 2028 DS DP
